Ten30 Biosciences — General Support

$5M

Funder

Coefficient Giving wiki

Recipient

Ten30 Biosciences

Program

Science and Global Health R&D Grantmaking

Date

Apr 2025

Source

coefficientgiving.org↗

Notes

[Scientific Research] Open Philanthropy recommended an investment of $5,000,000 in Ten30 Biosciences for general support. Ten30 Biosciences is a biotechnology company that is developing a novel oral drug to treat sickle cell disease, using an in-house platform that leverages AI and chemistry to discover therapeutics for challenging diseases. This falls within our focus area of scientific research.

Other Grants by Coefficient Giving

2625

Grant	Recipient	Amount	Date
National Association of Community and Restorative Justice — Restorative Justice Conference	National Association Of Community And Restorative Justice	$50K	Nov 2016
GiveDirectly — General Support (December 2017)	GiveDirectly	$2.5M	Dec 2017
gui2de — Zusha! Road Safety Campaign (December 2018)	Georgetown University	$100K	Dec 2018
Nuclear Threat Initiative — Planning Grant for Global Health Security Index	NTI \| bio (Nuclear Threat Initiative - Biological Program)	$477K	Feb 2017
Institute of the Black World — Criminal Justice Reform	Institute Of The Black World	$50K	Mar 2016
Living Goods — General Support (January 2019)	Living Goods	$100K	Jan 2019
IDinsight — General Support	IDinsight	$2M	Jun 2016
Vera Institute of Justice — New Orleans User-Funded Justice System	Vera Institute of Justice	$100K	Jul 2016
Iodine Global Network — General Support (January 2019)	Iodine Global Network	$100K	Jan 2019
Innovations for Poverty Action — Mindset Engagement in Cash Transfers	Innovations for Poverty Action	$350K	May 2016

Showing 10 of 2625 grants

← Back to Coefficient Giving All grants